What are some of the common symptoms of the COVID-19 disease?

Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle and body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.

What do I do if I have mild symptoms of COVID-19?

If you have milder symptoms like a fever, shortness of breath, or coughing: Stay home unless you need medical care. If you do need to go in, call your doctor or hospital first for guidance. Tell your doctor about your illness.

What are some of the symptoms of the new COVID-19 variant?

All of the variants, including delta and omicron, cause similar COVID-19 symptoms, including cough, fever and fatigue. There is some evidence that fewer people with omicron lose their taste and smell. Omicron is also less likely to cause severe disease such as pneumonia that may require treatment in the hospital.

How long does it take for COVID-19 symptoms to appear?

Symptoms usually appear 2 to 6 days after exposure to the virus. However, it sometimes takes longer — up to 14 days

Can I stay at home to recover if I have only mild symptoms of COVID-19?

Most people with COVID-19 have mild illness and can recover at home without medical care. Do not leave your home, except to get medical care. Do not visit public areas.

What medication can I take to reduce the symptoms of COVID-19?

In general, taking acetaminophen (Tylenol), naproxen (Aleve) ibuprofen (Advil or Motrin) can help lower fevers, help manage muscle aches and body pains and make the course of the illness a little bit more tolerable.

Who is considered a close contact to someone with COVID-19?

For COVID-19, a close contact is anyone who was less than 6 feet away from you for a combined total of 15 minutes or more over a 24-hour period. An infected person can transmit SARS-CoV-2, the virus that causes COVID-19, starting 48 hours (2 days) before they have symptoms or before they were tested.

Can you get the COVID-19 from someone who has no symptoms?

Both flu viruses and the virus that causes COVID-19 can be spread to others by people before they begin showing symptoms; by people with very mild symptoms; and by people who never experience symptoms (asymptomatic people).

Is there a drug treatment for COVID-19?

The U.S. Food and Drug Administration has approved one drug treatment for COVID-19 and has authorized others for emergency use during this public health emergency. In addition, many more therapies are being tested in clinical trials to evaluate whether they are safe and effective in combating COVID-19.

What are some of the possible prescription treatments for COVID-19?

Monoclonal antibody treatments could help the immune system recognize and respond more effectively to the virus. Oral antiviral medications that target specific parts of the SARS-CoV-2 virus can help reduce its multiplication and spread through the patient’s body.

Can Tylenol be used to treat COVID-19?

Acetaminophen, also called paracetamol or Tylenol, helps to reduce fevers and can definitely help manage muscle pain and body aches associated with COVID-19. Acetaminophen doesn’t treat the virus itself, nor does it reduce the duration of your illness.

What is the first drug that was approved by the FDA to treat COVID-19?

Remdesivir is the first drug approved by the FDA for treatment of hospitalized COVID patients over the age of 12.

What is Remdesivir?

Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.

Is Remdesivir approved for treatment of COVID-19?

Remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalized adult and pediatric patients (aged ≥12 years and weighing ≥40 kg).

When was Spikevax approved for COVID-19?

On January 31, 2022, the FDA announced the second approval of a COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine, and will now be marketed as Spikevax, for the prevention of COVID-19 in individuals 18 years of age and older.

Is Remdesivir approved in Europe for treatment of COVID-19?

Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but no invasive ventilation.

Can hydroxychloroquine help treat COVID-19?

See full answer

Current research suggests that hydroxychloroquine is not safe or effective for treating patients with COVID-19 (as of October 8, 2020). Early in the pandemic, patients may have received hydroxychloroquine under “Emergency Use Authorization,” but it did not reduce morbidity or mortality. The FDA announced a warning on using hydroxychloroquine on COVID-19 outside of the hospital setting due to the risk of heart rhythm problems (source). Hydroxychloroquine during this pandemic has taught scientists to be more cautious of using drugs as emergency treatments without evidence from trials (source). The best way to learn how to treat COVID-19 is to conduct randomized controlled clinical trials, but many hydroxychloroquine studies have been stopped early due to safety concerns.

When was the first case of the COVID-19 variant Omicron identified in the US?

December 1, 2021: The first confirmed U.S. case of Omicron was identified.

When was Pfizer-BioNTech COVID-19 vaccine approved?

Pfizer-BioNTech (COMIRNATY) received U.S. Food and Drug Administration (FDA) approval on August 23, 2021, for individuals 16 years of age and older. Once vaccines are approved by the FDA, companies can market the vaccines under brand names. COMIRNATY is the brand name for the Pfizer-BioNTech COVID-19 Vaccine.

When was Johnson and Johnson COVID-19 vaccine approved?

The Johnson & Johnson single-shot COVID-19 vaccine, developed by its Janssen Pharmaceutical Companies of Johnson & Johnson, received an EUA in the United States on February 27, 2021 and Conditional Marketing Authorization (CMA) by the European Commission on March 11.

Has the Omicron COVID-19 variant been detected in the US?

CDC is working with state and local public health officials to monitor the spread of Omicron. As of December 20, 2021, Omicron had been detected in most states and territories and continues to be the dominant variant in the United States.

Can a PCR test detect the COVID-19 Omicron variant?

The good news is that, according to the World Health Organization (WHO), PCR and rapid antigen tests can still detect Omicron as well as previous variants.